Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$166K Sell
1,294
-519
-29% -$60.7K 0.1% 170
2026
Q1
$218K Sell
1,813
-2,010
-53% -$232K 0.15% 99
2025
Q4
$403K Sell
3,823
-1,627
-30% -$153K 0.21% 62
2025
Q3
$458K Buy
5,450
+423
+8% +$34.8K 0.25% 37
2025
Q2
$398K Buy
5,027
+2,479
+97% +$197K 0.23% 47
2025
Q1
$229K Buy
2,548
+58
+2% +$5.42K 0.15% 114
2024
Q4
$248K Buy
2,490
+1,342
+117% +$138K 0.16% 97
2024
Q3
$130K Buy
1,148
+10
+0.9% +$1.19K 0.08% 376
2024
Q2
$141K Buy
1,138
+114
+11% +$14.7K 0.09% 306
2024
Q1
$135K Sell
1,024
-115
-10% -$14.2K 0.09% 331
2023
Q4
$124K Sell
1,139
-1,138
-50% -$118K 0.08% 360
2023
Q3
$234K Buy
2,277
+72
+3% +$7.76K 0.18% 73
2023
Q2
$255K Sell
2,205
-333
-13% -$37.8K 0.19% 64
2023
Q1
$270K Sell
2,538
-266
-9% -$28.7K 0.24% 49
2022
Q4
$311K Buy
2,804
+375
+15% +$38.3K 0.25% 47
2022
Q3
$209K Sell
2,429
-2,391
-50% -$213K 0.18% 76
2022
Q2
$440K Buy
4,820
+1,750
+57% +$155K 0.35% 25
2022
Q1
$252K Buy
3,070
+2,211
+257% +$174K 0.17% 93
2021
Q4
$66K Buy
+859
New +$68.4K 0.09% 370

Other funds holding MRK

Covestor's MRK Position: Q2 2026 in Review

Covestor reduced its Merck (MRK) stake by 29% in Q2 2026, selling an estimated $60.7K and leaving 1,294 shares worth $166K. The position accounts for 0.1% of the portfolio, ranked #170.

Covestor first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $458K in Q3 2025. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Covestor held 1,294 shares of Merck worth $166K as of Q2 2026.
  • Covestor sold 519 Merck shares in Q2 2026, an estimated $60.7K.
  • Merck made up 0.1% of Covestor's portfolio in Q2 2026, its #170 holding.
  • Covestor first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Merck position peaked at $458K in Q3 2025.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.